A Study of the Pharmacokinetics and Antiviral Activity of Dolutegravir in the Central Nervous System in HIV-1 Infected ART-naive Subjects

Clinical trial NCT01499199 · COMPLETED

Trial details

NCT number: NCT01499199
Sponsor: ViiV Healthcare
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Infection, Human Immunodeficiency Virus

Start date: 2012-01-01
Primary completion: 2012-10-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.